Clinical trial

Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate…

NCT00311623 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed

Key facts

NCT number NCT00311623
Title Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
Official title A Pharmacodynamic Study of Pre-Prostatectomy Rapamycin in Men With Advanced Localized Prostate Cancer
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Prostate Cancer
Intervention type Drug, Procedure
Interventions Rapamycin 3mg, Rapamycin 6mg, Radical prostatectomy
Enrollment 32
Start date Aug 1, 2006
Primary completion Jan 1, 2008
Completion Jun 1, 2010
First posted Apr 6, 2006
Last update posted Feb 22, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies